AstraZeneca Pharma India Ltd. — AGM Information 2020

Aug 11, 2020

==> picture [522 x 90] intentionally omitted <==

August 11, 2020

The Manager- Listing BSE Limited Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai - 400001

National Stock Exchange of India Limited

Exchange plaza, 5[th] Floor, Plot No.C/1, G Block Bandra –Kurla Complex, Bandra (E), Mumbai - 400051

Dear Sir,

Sub: Summary of Proceedings of 41[st] Annual General Meeting – Ref: Scrip code BSE: 506820, NSE: ASTRAZEN

Pursuant to the provisions of Regulation 30 read with Part A of Schedule III to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the following business were transacted at the 41[st] Annual General Meeting (AGM) of the Company held on August 10, 2020 at 3.00 P.M. through Video Conferencing/Other Audio Visual Mode:

1. Adoption of Financial Statements for the financial year ended March 31, 2020 and the Reports of the Board of Directors and Auditors thereon.

2. Confirmation of the payment of interim dividend of Re. 1/- per Equity Share for the financial year 2019-20.

3. Appointment of Ms. Weiying Sarah Wang (DIN: 08369289), Non-Executive Director who retires by rotation, and being eligible, offers herself for re- appointment.

4. Appointment of Mr. Ankush Nandra (DIN: 08737981) as a Non Executive Director.

5. Re-appointment of Mr. Gagandeep Singh Bedi (DIN: 07844333) as the Managing Director of the Company, for a term of 3 years w.e.f. July 1, 2020.

==> picture [452 x 64] intentionally omitted <==

==> picture [572 x 98] intentionally omitted <==

1. Re-Appointment of Mr. Rajesh Marwaha (DIN: 01458768) as a Whole-time Director of the Company for a term of 3 years w.e.f. December 2, 2019.

2. Ratification of Cost Auditor’s remuneration.

Kindly note that voting results will be announced upon the receipt of Scrutinizer’s Report and will be submitted as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Please take same on record.

For AstraZeneca Pharma India Limited

Digitally signed by PRATAP PRATAP RUDRA RUDRA BHUVANAGIRI BHUVANAGIRI Date: 2020.08.11 19:57:19 +05'30'

Pratap Rudra Company Secretary & Legal Counsel

==> picture [452 x 64] intentionally omitted <==